Ignite Creation Date:
2024-05-05 @ 10:49 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01199393
Status:
COMPLETED
Last Update Posted:
2015-07-29
First Post:
2010-08-31
Brief Title:
Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Study Overview
Official Title:
Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators want to research whether genetic polymorphisms of drug-metabolizing enzymes can be used to predict chemotherapeutic outcomes in patients with metastatic breast cancer
Detailed Description:
1 Patients evaluation On all patients a complete clinical history and physical examination is performed including routine hematology and biochemistry analyses Hematology and biochemistry analyses are repeated at the end of each cycle Toxicity is classified according to WHO criteria at each cycle for each patient Response is assessed after two cycles of chemotherapy and every two cycles thereafter using Response Evaluation Criteria in Solid Tumor Group RECIST guidelines
2 Sample collection and SNP genotyping Venous blood 4 ml is collected from each subject and placed into tubes containing EDTA Genomic DNA is isolated with a DNA Blood isolation kitGenotypes are performed by PCR-RFLP PCR-DHPLC and PCR-direct sequencing etc
3 Statistical Analysis x2 test is used to summarize the association of response and adverse events to chemotherapy with genetic polymorphisms
2 Sample collection and SNP genotyping Venous blood 4 ml is collected from each subject and placed into tubes containing EDTA Genomic DNA is isolated with a DNA Blood isolation kitGenotypes are performed by PCR-RFLP PCR-DHPLC and PCR-direct sequencing etc
3 Statistical Analysis x2 test is used to summarize the association of response and adverse events to chemotherapy with genetic polymorphisms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None